- Home
- ERII vs QURE Comparison
ERII vs QURE Comparison
Compare ERII & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERII
- QURE
- Stock Information
- Founded
- ERII 1992
- QURE 1998
- Country
- ERII United States
- QURE Netherlands
- Employees
- ERII N/A
- QURE N/A
- Industry
- ERII Industrial Machinery/Components
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- ERII Technology
- QURE Health Care
- Exchange
- ERII Nasdaq
- QURE Nasdaq
- Market Cap
- ERII 851.0M
- QURE 860.8M
- IPO Year
- ERII 2008
- QURE 2007
- Fundamental
- Price
- ERII $14.58
- QURE $16.05
- Analyst Decision
- ERII Strong Buy
- QURE Strong Buy
- Analyst Count
- ERII 4
- QURE 8
- Target Price
- ERII $20.75
- QURE $39.43
- AVG Volume (30 Days)
- ERII 273.2K
- QURE 1.1M
- Earning Date
- ERII 02-26-2025
- QURE 02-26-2025
- Dividend Yield
- ERII N/A
- QURE N/A
- EPS Growth
- ERII 22.95
- QURE N/A
- EPS
- ERII 0.33
- QURE N/A
- Revenue
- ERII $135,062,000.00
- QURE $28,587,000.00
- Revenue This Year
- ERII $15.22
- QURE $153.92
- Revenue Next Year
- ERII $13.90
- QURE N/A
- P/E Ratio
- ERII $43.63
- QURE N/A
- Revenue Growth
- ERII 19.05
- QURE N/A
- 52 Week Low
- ERII $12.26
- QURE $3.73
- 52 Week High
- ERII $20.27
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- ERII 47.17
- QURE 56.44
- Support Level
- ERII $13.94
- QURE $14.87
- Resistance Level
- ERII $14.71
- QURE $16.07
- Average True Range (ATR)
- ERII 0.37
- QURE 0.87
- MACD
- ERII 0.06
- QURE -0.11
- Stochastic Oscillator
- ERII 50.00
- QURE 77.40
About ERII Energy Recovery Inc.
Energy Recovery Inc is an engineering-driven technology company. It is engaged in engineering, designing, manufacturing and supplying solutions that make industrial processes more efficient and sustainable. The company operates in three segments, Water, Emerging Technologies and Corporate. It offers energy recovery devices (ERDs) and pumps as well as related products and services to the global reverse osmosis desalination market. The company derives a majority of the revenue from the Water segment. Geographically, the company operates in the U.S. and other international countries.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.